The Alzheimer’s Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans

INTRODUCTION: We describe Alzheimer’s Disease Neuroimaging Initiative (ADNI) Biomarker Core progress including: the Biobank; cerebrospinal fluid (CSF) amyloid beta (Aβ(1–42)), t-tau, and p-tau(181) analytical performance, definition of Alzheimer’s disease (AD) profile for plaque, and tangle burden d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement
Autors principals: Kang, Ju-Hee, Korecka, Magdalena, Figurski, Michal J., Toledo, Jon B., Blennow, Kaj, Zetterberg, Henrik, Waligorska, Teresa, Brylska, Magdalena, Fields, Leona, Shah, Nirali, Soares, Holly, Dean, Robert A., Vanderstichele, Hugo, Petersen, Ronald C., Aisen, Paul S., Saykin, Andrew J., Weiner, Michael W., Trojanowski, John Q., Shaw, Leslie M.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5127404/
https://ncbi.nlm.nih.gov/pubmed/26194312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2015.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars